Back
Enfusion Vs. F5 Industry Stock Comparison
Buy
62
ENFN
Enfusion
Last Price:
10.36
Seasonality Move:
-15.88%
Buy
67
FFIV
F5
Last Price:
246.92
Seasonality Move:
2.22%
Buy
62
Enfusion (ENFN)
is a Buy
Is Enfusion a Buy, Sell or Hold?
- The current Enfusion [ENFN] share price is $10.36. The Score for ENFN is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- ENFN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
67
F5 (FFIV)
is a Buy
Is F5 a Buy, Sell or Hold?
- The current F5 [FFIV] share price is $246.98. The Score for FFIV is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- FFIV is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FFIV Stock Price Chart
ENFN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.29 | Buy |
Relative Strength Index (14 RSI): | 72.17 | Buy |
Chaikin Money Flow: | 390693 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.93 - 9.79) | Buy |
Bollinger Bands (100): | (8.28 - 9.44) | Buy |
FFIV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.82 | Buy |
Relative Strength Index (14 RSI): | 67.93 | Buy |
Chaikin Money Flow: | 156641 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (223.57 - 245.13) | Buy |
Bollinger Bands (100): | (185.88 - 229.58) | Buy |
ENFN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.88 | Buy |
20-day SMA: | 9.46 | Buy |
50-day SMA: | 9.17 | Buy |
200-day SMA: | 8.96 | Buy |
8-day EMA: | 9.9 | Buy |
20-day EMA: | 9.57 | Buy |
50-day EMA: | 9.21 | Buy |
200-day EMA: | 9.03 | Buy |
FFIV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 242.53 | Buy |
20-day SMA: | 238.9 | Buy |
50-day SMA: | 226.44 | Buy |
200-day SMA: | 193.57 | Buy |
8-day EMA: | 242.64 | Buy |
20-day EMA: | 237.76 | Buy |
50-day EMA: | 226.46 | Buy |
200-day EMA: | 198.39 | Buy |
Enfusion Earnings Growth & ENFN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.07 per share, and an increase next year of $0.08 per share.
F5 Earnings Growth & FFIV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.73 per share, and an increase next year of $1.12 per share.
Enfusion Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
F5 Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |